文献速递心境障碍

抑郁症心理治疗的长期效果:一项高级meta分析

Long-term effects of psychotherapies for depression: an advanced meta-analysis.
PubMed 文献 · World Psychiatry · 2026-01-01

该meta分析纳入191项RCT共33,691名成人抑郁症患者,比较心理治疗与对照条件的长期效果。心理治疗效应在12周达SMD 0.55,一年左右降至0.39并保持稳定,SMD在随机化后8.3年内仍显著。

要点

  • 心理治疗对成人抑郁症在3个月时效应为中到大(SMD 0.55)。
  • 效应在随后9个月缓慢降至中等水平(约1年时SMD 0.39)并多年保持稳定。
  • SMD在随机化后长达8.3年仍具统计学显著性。

核心结论

  • 心理治疗对成人抑郁症在随机化后3个月有中到大效应,随后9个月缓慢降至中等水平,并在此后数年内保持稳定中等效应。

研究设计与样本

  • 纳入比较成人抑郁症心理治疗与对照条件(常规照护、等待名单或其他)且报告随机化后6个月或更晚结局的随机对照试验(RCT)。
  • 共纳入191项RCT、209个治疗与对照比较、33,691名参与者(治疗组17,715人,对照组15,976人),含534次随访测量,其中52次(9.7%)在随机化后12个月以上。
  • 采用多变量合并模型与三次回归样条评估随时间变化的效应,并以连续时间自回归方差-协方差矩阵建模真实效应的依赖性。

主要发现

  • 长期SMD的最佳拟合限制性三次样条模型(5个基函数)显示SMD从基线升至12周时的0.55,随后逐渐降至约一年随访时的0.39,此后基本稳定。
  • SMD在随机化后长达8.3年(431个月)仍具统计学显著性。
  • 应答率的风险比(RR)在3个月后升至1.68,随时间缓慢下降至5年随访时的1.14,RR在长达4.5年(236周)仍显著。

关键数值与推荐

  • 主要结局为标准化均数差(SMD),同时考察治疗组与对照组的应答率及相应风险比(RR)。
  • SMD在12周为0.55,约一年为0.39,并保持统计显著至随机化后8.3年(431个月)。
  • 应答RR在3个月为1.68,5年随访为1.14,并保持显著至4.5年(236周)。

临床怎么用

  • 临床可预期心理治疗对成人抑郁症在3个月时产生中到大效应,随后效应缓慢减弱但长期维持中等水平。
  • 长期随访中应关注心理治疗效应的自然衰减,并在一年左右评估是否需要巩固或加强干预。

局限性

  • 仅9.7%的随访测量发生在随机化后12个月以上,长期数据相对有限。
  • 纳入试验的对照条件包括常规照护、等待名单或其他,异质性可能影响长期效应估计。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

It is well-established that psychotherapies are effective in the treatment of depression. It remains unclear, however, whether the effects persist over the long term. We conducted a comprehensive meta-analysis examining the long-term effects of psychotherapies for depression compared with control conditions. We included randomized controlled trials (RCTs) comparing psychotherapies for adult depression with control conditions (care-as-usual, waitlist, or other) that reported outcomes at six months after randomization or later. The standardized mean difference (SMD) was the main outcome, but we also examined response rates in the treatment and control groups and the relevant risk ratio (RR). We evaluated the effectiveness of psychotherapies over time using a multivariate pooling model with cubic regression splines to allow for potentially non-linear interactions. Dependencies in the true effects were modeled using continuous-time autoregressive variance-covariance matrices. We included 191 RCTs with 209 comparisons between treatment and control groups, involving 33,691 participants (17,715 in the treatment, 15,976 in the control conditions). The trials encompassed 534 follow-up measurements, of which 52 (9.7%) occurred more than 12 months after randomization. The best fitting restricted cubic spline model for long-term SMDs (5 basis functions) indicated that the SMD increased from baseline to 0.55 at 12 weeks, then gradually decreased to 0.39 at around one-year follow-up, and remained largely stable thereafter. The SMD remained statistically significant up to 8.3 years (431 months) after randomization. The RR for response went up to 1.68 after 3 months and slowly decreased over time to 1.14 at 5-year follow-up. The RR remained significant up to 4.5 years (236 weeks). We conclude that psychotherapies have moderate to large effects at 3 months after randomization, which slowly decrease during the next 9 months to a moderate level, and remain stably moderate for several years.

来源:World Psychiatry,查看原文。版权归原作者所有。

引用

  1. Cuijpers P, Miguel C, Kaya Aglio E, et al. Long-term effects of psychotherapies for depression: an advanced meta-analysis. World Psychiatry. 2026. PMID: 42136430. doi:10.1002/wps.70065

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。